Universe Pharmaceuticals INC Sustainability Profile
Universe Pharmaceuticals Inc., headquartered in China, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in 2003, the company has established a strong presence in major operational regions across Asia and beyond, focusing on both prescription and over-the-counter medications. With a commitment to quality and efficacy, Universe Pharmaceuticals offers a diverse range of products, including generic drugs and specialty pharmaceuticals. Their unique approach to research and development has led to several key milestones, positioning them as a trusted name in the market. Notably, the company has received various certifications that underscore its dedication to regulatory compliance and product safety, further solidifying its reputation in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Universe Pharmaceuticals INC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Universe Pharmaceuticals INC's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Universe Pharmaceuticals INC's reported carbon emissions
Universe Pharmaceuticals INC, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing greenhouse gas emissions at this time. It is important to note that Universe Pharmaceuticals INC is a current subsidiary and may inherit emissions data and climate initiatives from its parent organisation. However, no specific data or initiatives have been provided from the parent company or any other sources. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate strategies and transparency in emissions reporting. As of now, Universe Pharmaceuticals INC has not publicly committed to any industry-standard climate initiatives such as Science Based Targets (SBTi) or the Carbon Disclosure Project (CDP).
How Carbon Intensive is Universe Pharmaceuticals INC's Industry?
How Carbon Intensive is Universe Pharmaceuticals INC's Location?
Universe Pharmaceuticals INC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Universe Pharmaceuticals INC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
